Concepedia

Author

Shigeki Yoshiura

Chugai Pharma (United States)ORCID

Also Known As

Shigeki Yoshiura

46

Publications

178

Citations

6

H-Index

15

Concepts

All Affiliations

Chugai Pharma (United States)
SY

About

Shigeki Yoshiura is an author at Chugai Pharma (United States) specializing in cell biology, medicine, and immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

83

2

Cell Biology

2

2

83

3

Immunology

1

1

23

4

Pathology

1

1

23

5

Autoimmunity

1

1

23

Shigeki Yoshiura

×

6

Publications

153

Citations

6

H-Index

YearCitations

Tre1 GPCR Signaling Orients Stem Cell Divisions in the Drosophila Central Nervous System

Shigeki Yoshiura, Nao Ohta, Fumio Matsuzaki

Developmental Cell

2011

60

Reconstruction of Par-dependent polarity in apolar cells reveals a dynamic process of cortical polarization

K. Kono, Shigeki Yoshiura, Ikumi Fujita,

eLife

2019

32

The molecular rationale for the combination of polatuzumab vedotin plus rituximab in diffuse large B‐cell lymphoma

Natsumi Kawasaki, Yukari Nishito, Yasushi Yoshimura,

British Journal of Haematology

2022

23

FGFR blockade inhibits targeted therapy-tolerant persister in basal FGFR1- and FGF2-high cancers with driver oncogenes

Koh Furugaki, Takaaki Fujimura, Hayato Mizuta,

npj Precision Oncology

2023

15

Obinutuzumab in Combination with Chemotherapy Enhances Direct Cell Death in CD20-Positive Obinutuzumab-resistant Non-Hodgkin Lymphoma Cells

Takaaki Fujimura, Yoriko Yamashita‐Kashima, Natsumi Kawasaki,

Molecular Cancer Therapeutics

2021

13

Resistance to obinutuzumab-induced antibody-dependent cellular cytotoxicity caused by abnormal Fas signaling is overcome by combination therapies

Natsumi Kawasaki, Yoriko Yamashita‐Kashima, Takaaki Fujimura,

Molecular Biology Reports

2022

10

Page 1